التفاصيل البيبلوغرافية
| العنوان: |
Evaluating Hepatitis B Virus Reactivation During Solid Tumor Chemotherapy: Evidence to Guide Pretreatment Hepatitis B Screening and Prophylaxis. |
| المؤلفون: |
Lo Re III, Vincent, Schuster, Mindy, Lo Re, Vincent 3rd |
| المصدر: |
Annals of Internal Medicine; 1/5/2016, Vol. 164 Issue 1, p64-65, 2p |
| مصطلحات موضوعية: |
HEPATITIS B virus, CANCER chemotherapy, TUMORS, DRUG laws, MEDICAL screening, PATIENTS |
| مصطلحات جغرافية: |
UNITED States |
| الشركة/الكيان: |
UNITED States. Food & Drug Administration |
| مستخلص: |
The author discusses on study on risk for reactivation of hepatitis B virus (HBV) infection with chemotherapy for solid tumors. He states that the U.S. Food and Drug Administration has issued drug safety communication regulation urging health care providers to screen patients for HBV infection before starting treatment with B-cell depleting agents. He also mentions that risk for HBV reactivation in patient with infection receiving chemotherapy can be reduced using antiviral prophylaxis drug. |
| قاعدة البيانات: |
Complementary Index |